Our experiments confirmed that reducing HIF-1α while increasing CD47 in GBM cells significantly enhances malignant proliferation, colony formation and tumor cell migration, indicating that HIF-1α can modulate GBM characteristics via the CD47 protein. The gene discussed is HIF1A; the disease is glioblastoma.